We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Zabdeno

News List

Johnson & Johnson to donate 200,000 vaccine regimens to curb Ebola outbreak europeanpharmaceuticalreview
May 18, 2021
To prevent the spread of the Ebola virus in West Africa, Johnson & Johnson is donating vaccines for a WHO early access clinical programme.
New vaccine for Ebola among CHMP recommendations pharmatimes
June 02, 2020
Johnson and Johnson's experimental two-stage vaccine for protection against Ebola virus disease is among eight medicines backed by the European Medicines Agency's human medicines committee (CHMP) at its May meeting.
New vaccine for prevention of Ebola virus disease recommended for approval in the EU expresspharma
June 01, 2020
The new Ebola vaccine consists of two components, Zabdeno (Ad26.ZEBOV) and Mvabea (MVA-BN-Filo). Zabdeno is given first and Mvabea is administered approximately eight weeks later as a booster.